| Serial Number | 98201386 |
| Word Mark | ASKFIRST |
| Filing Date | Thursday, September 28, 2023 |
| Status | 661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED |
| Status Date | Monday, November 4, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Pseudo Mark | ASK FIRST |
| Goods and Services | Promoting collaboration between scientists, technicians, clinical specialists, patients, and their families to advance therapeutics, technology, regulatory requirements, and public policy in the field of healthcare, genetic disease, gene therapy, and clinical trials; promoting the interests of patients by means of public advocacy in the field of genetic disease and gene therapy |
| Goods and Services | Providing patient advocate services in the field of genetic disease, gene therapy, and potential curative therapies; providing personal support services for patients, namely, emotional counseling and emotional support by providing information in the fields of genetic disease, gene therapy, and potential curative therapies; providing patient advocacy and personal emotional support services to potential participants and participants in clinical trials for genetic diseases and gene therapy; providing information in the field of personal emotional support of gene therapy patients and patients' families |
| Goods and Services | Providing medical and scientific research information in the field of gene therapy, and clinical trials; Consulting services for others in the field of designing clinical trials; Medical and scientific research, namely, designing clinical trials for others |
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, October 11, 2023 |
| Primary Code | 035 |
| First Use Anywhere Date | Sunday, June 14, 2020 |
| First Use In Commerce Date | Sunday, June 14, 2020 |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, October 11, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 045 - Legal services; security services for the protection of property and individuals; personal and social services rendered by others to meet the needs of individuals. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, October 11, 2023 |
| Primary Code | 045 |
| First Use Anywhere Date | Sunday, June 14, 2020 |
| First Use In Commerce Date | Sunday, June 14, 2020 |
| Party Name | Asklepios BioPharmaceutical, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Research Triangle Park, NC 27709 |
| Event Date | Event Description |
| Monday, October 2, 2023 | NEW APPLICATION ENTERED |
| Wednesday, October 11, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, February 2, 2024 | ASSIGNED TO EXAMINER |
| Wednesday, May 8, 2024 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
| Thursday, February 8, 2024 | NON-FINAL ACTION WRITTEN |
| Thursday, February 8, 2024 | NON-FINAL ACTION E-MAILED |
| Thursday, February 8, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, May 8, 2024 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
| Wednesday, May 8, 2024 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Wednesday, May 8, 2024 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Wednesday, May 8, 2024 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Wednesday, May 8, 2024 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Wednesday, May 8, 2024 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Thursday, August 8, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, November 4, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, November 4, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, November 4, 2024 | ASSIGNED TO LIE |